Related Experiment Videos
Phenytoin dosage predictions in paediatric patients
G J Yuen1, P T Latimer, L C Littlefield
1School of Pharmacy, University of Maryland, Baltimore.
Insights
Adjusting phenytoin dosage in children is complex. This study compared two methods, finding no significant difference in accuracy, but the Bayesian approach offered more consistent predictions for phenytoin dosing in pediatric patients. Close patient monitoring is essential.
Area of Science:
- Pharmacokinetics
- Pediatric Pharmacology
- Drug Metabolism
Background:
- Phenytoin dosing in pediatric patients presents challenges due to growth-related changes and saturable metabolism.
- Accurate dosage adjustments are crucial for therapeutic efficacy and safety in children.
Purpose of the Study:
- To evaluate two pharmacokinetic methods for adjusting phenytoin dosage in pediatric patients based on a single dosing-rate/steady-state concentration pair.
- To compare the predictability, bias, and precision of a Bayesian forecaster versus a fixed Vmax method.
Main Methods:
- Retrospective analysis of 34 pediatric patients with 48 predictions.
- Utilized a Bayesian forecaster and a fixed Vmax method with different a priori parameter estimates.
- Assessed methods based on absolute predictability, bias (mean error), and precision (root mean squared error).
Main Results:
- No significant differences in predictability, bias, or precision were found among the five evaluated methods.
- The Bayesian algorithm demonstrated greater robustness, providing predictions in all cases, unlike fixed Vmax methods.
- All methods showed a tendency for overprediction of dosage, with poorer results for steady-state concentration predictions.
Conclusions:
- Both Bayesian and fixed Vmax methods have limitations in phenytoin dosage adjustment for pediatric patients.
- The Bayesian method offers more consistent predictions across various scenarios.
- Close patient monitoring remains critical regardless of the chosen dosage adjustment method.
Abstract:
Phenytoin dosing in paediatric patients is complicated both by alterations in patient requirements due to growth and maturation changes and by the capacity-limited characteristics of phenytoin metabolism. This study examines 2 pharmacokinetic methods to adjust phenytoin dosage based on a single dosing-rate/steady-state serum phenytoin concentration pair. A Bayesian forecaster and a fixed parameter [rate of metabolism (Vmax)] method were examined with previously published sets of a priori parameter estimates. The fixed Vmax method was utilised with the parameter derived from native Japanese (method 1), US Caucasian (method 2) and European (method 3) patients. The Bayesian forecaster used a priori parameter estimates obtained from native Japanese (method 4) and European (method 5) patients. Each method was examined retrospectively in 34 paediatric patients with a total of 48 predictions possible. Measures of absolute predictability, bias (mean error, % dose) and precision (root mean squared error, % dose), were -3.58/12.2, -1.51/12.2, 4.06/9.96, -4.38/13.2, and -3.10/11.5, for methods 1, 2, 3, 4 and 5, respectively. There was no significant difference among the 5 methods. However, the Bayesian algorithm tended to be more robust over a broad range of situations, providing predictions in all cases. The fixed Vmax methods could not provide predictions in every case. Finally, all methods had a significant number of overpredictions of dosage. Poorer results were observed when prediction of steady-state serum concentrations were performed, partly due to the retrospective nature of the study. We conclude that close monitoring of patients, regardless of the method chosen to adjust dosage, is recommended.